Evidence map›Paper›PMID 41426450›Full record

ArticleFrontiers in sleep2023

Optimizing the Better Nights, Better Days for Children with Neurodevelopmental Disorders program for large scale implementation.

Alzena Ilie, Matt Orr, Shelly Weiss, Isabel M Smith, Graham J Reid, Ana Hanlon-Dearman, Cary Brown, Evelyn Constantin, Roger Godbout, Sarah Shea and 2 more

Abstract read
In one paragraph

Article in Frontiers in sleep, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alzena IlieDepartment of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.
Matt OrrDepartment of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.
Shelly WeissDepartment of Paediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Isabel M SmithDepartment of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.
Graham J ReidDepartments of Psychology, Family Medicine, and Paediatrics, The University of Western Ontario, London, ON, Canada.
Ana Hanlon-DearmanDepartments of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Cary BrownFaculty of Rehabilitation Medicine, University of Alberta, Edmonton, AB, Canada.
Evelyn ConstantinPediatric Sleep Medicine and Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montréal, QC, Canada.
Roger GodboutDepartment of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Sarah SheaDepartment of Pediatrics, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
Osman S IpsirogluDevelopmental Pediatrics and Respirology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Penny V CorkumDepartment of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Pediatric insomnia is one of the most commonly reported disorders, especially in children with neurodevelopmental disorders. Method: Twenty parents who had been randomized to the treatment condition of the RCT participated in this study. These parents participated in virtual semi-structured qualitative interviews about their experiences with the Results: Overall, more facilitators than barriers were identified for Reach, Effectiveness, Implementation, and Maintenance, whereas for Adoption more barriers emerged. Participants who were engaged reported more facilitators about the Conclusion: With this feedback from participants, we can optimize

Indexed as

barriers and facilitatorsbehavioral interventionchildreneHealthinsomniainterventionneurodevelopmental disorders (NDDs)transdiagnostic

Identifiers

PMID41426450
PMCPMC12713869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.